Home / Contributors / Alan F. Schatzberg
Alan F. Schatzberg

Alan F. Schatzberg, M.D.

Dr. Schatzberg's research examines the biology and psychopharmacology of depressive disorders. Past studies include norepinephrine systems in depression as a means of subtyping, the development of delusions in major depression, and the clinical pharmacology of nondelusional depression with a focus on chronic depression. He was elected into the Institute of Medicine of the National Academy of Sciences in 2003, and he holds co-editor, editorial board, or presidential positions with several journals and societies.

Positions

  • Kenneth T. Norris, Jr., Professor, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA
  • Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine

 

Education

  • M.D., 1968, New York University School of Medicine, Medicine

 

Relevant Publications

  • Lyons DM, Parker KJ, Zeitzer JM, Buckmaster CL, Schatzberg AF. Preliminary evidence that hippocampal volumes in monkeys predict stress levels of adrenocorticotropic hormone. Biol Psychiatry. 2007;62(10):1171-1174.
  • Ohayon MM, Schatzberg AF. Biomarkers and classifications. J Psychiatr Res. 2007;41(8):623-624.
  • Buckley TM, Mullen BC, Schatzberg AF. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls. Psychoneuroendocrinol. 2007;32(8-10):859-864.
  • Schatzberg AF. Safety and tolerability of antidepressants: weighing the impact on treatment decisions. J Clin Psychiatry. 2007;68(suppl 8):26-34.
  • Schatzberg AF, Cole JO, DeBattista C. Manual of Clinical Psychopharmacology. 6th ed. Washington, D.C.: American Psychiatric Publishing; 2007.

 

Contributed Content